Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EIF4E2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OASL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HMG20B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PQBP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DDX58 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GRHPR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC101928623 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ALKBH1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
VPS45 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LGALS8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HTRA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYB561D2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GTF2A2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PSEN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KMO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COX5B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC12A9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RAB22A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LAMTOR5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on